Status:
COMPLETED
Group Version of the UP-A in a Spanish Public Mental Health Setting.
Lead Sponsor:
Universidad Nacional de Educación a Distancia
Collaborating Sponsors:
Puerta de Hierro University Hospital
Conditions:
Anxiety Disorders
Depressive Disorder
Eligibility:
All Genders
11-18 years
Phase:
NA
Brief Summary
The study aims to adapt the Spanish version of the UP-A to a group format in a public mental health setting for adolescents with moderate emotional symptoms and evaluate its clinical utility and feasi...
Detailed Description
Anxiety and depression are among the most prevalent mental health disorders in adolescents, with growing concerns about their increasing incidence. Studies indicate that emotional disorders often co-o...
Eligibility Criteria
Inclusion
- Presenting a primary diagnosis of an emotional disorder with mild or moderate severity, including the following disorders based on DSM-5 categories: Depressive Disorders (Major Depressive Disorder and Persistent Depressive Disorder), Anxiety Disorders (Specific Phobia, Panic Disorder, Agoraphobia, Social Anxiety Disorder, Generalized Anxiety Disorder), Obsessive-Compulsive and Related Disorders (including Body Dysmorphic Disorder, Hoarding Disorder, Trichotillomania and Excoriation (Skin-Picking) Disorder), Trauma and Stressor-Related Disorders (Reactive Attachment Disorder, Post-Traumatic Stress Disorder, Acute Stress Disorder and Adjustment Disorders), Dissociative Disorders (Dissociative Identity Disorder, Depersonalization/Derealization Disorder) and Somatic Symptom and Related Disorders (Somatic Symptom Disorder and Illness Anxiety Disorder). Specified and unspecified disorders from the above categories were also included.
- Being 11-18 years of age
- Being proficient in Spanish
- The adolescent being able to attend the treatment sessions
- At least one of the adolescent's parents or legal guardians being able to attend the parents' treatment sessions
- If the participant was taking psychiatric medication, the dose was required to remain stable for at least 1 month before the start of treatment and throughout it
Exclusion
- Presenting self-harm or suicidal ideation in a moderate or severe degree
- Presenting certain of the following clinical conditions (either as a main or comorbid diagnosis): Neurodevelopmental Disorders (Intellectual Disability or Autism Spectrum Disorder); Disruptive, Impulse-Control and Conduct Disorders; Eating Disorders; Psychotic Spectrum Disorders or psychotic-type symptoms,; Substance Abuse Disorders (excluding cannabis, coffee and/or nicotine); high severity Emotional Disorders; and Bipolar Disorders
- The characteristics or severity of the symptoms presented by the adolescent requiring an individual intervention or one adapted to the specific clinical condition
- Be receiving public or private psychological treatment during the UP-A program
- Suffering from a serious medical illness that made the adolescent's participation in the treatment program unsustainable
- The participant, or if under 16 years of age, his or her parents, having refused to sign the informed consent
Key Trial Info
Start Date :
November 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2025
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT06894368
Start Date
November 17 2022
End Date
July 15 2025
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Salud Mental de Majadahonda
Madrid, Madrid, Spain, 28221